Exelixis reported $1.83B in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1064.23M 241.05M
AstraZeneca AZN:LN 26.24B 447M
Bayer BAYN:GR 32.58B 633M
Cytokinetics CYTK:US $ 623.53M 87.85M
Eisai 4523:JP Y 587057M 16340M
Genmab GEN:DC 23.18B 439M
Immunogen IMGN:US $ 456.72M 22.03M
IONIS PHARMACEUT IONS:US $ 2345M 189.26M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Novartis NOVN:VX 45.72B 19.46B
Xencor XNCR:US $ 505.97M 81.6M